First Defense Calf Health
About First Defense Calf Health
First Defense Calf Health is the consumer-facing brand of ImmuCell Corporation (NASDAQ: ICCC), an animal health biotechnology company founded in 1982 and headquartered in Portland, Maine. The company pioneered the use of antibody therapy for calf scours prevention, developing USDA-approved veterinary biologics that deliver immediate passive immunity to newborn calves. Unlike vaccines that require calves to develop their own immune response, First Defense products provide preformed, potency-tested antibodies that protect immediately upon administration. The product line covers the three most common scours-causing pathogens: K99+ E. coli, bovine coronavirus, and rotavirus. First Defense antibodies are purified from hyper-immunized colostrum collected from donor cows on a strict commercial scours vaccine program, combined with ImmuCell's proprietary vaccine regimen featuring virus-like particle (VLP) technology developed in collaboration with Baylor College of Medicine. All products are approved by the USDA Veterinary Center for Biologics, the same agency that approves scours vaccines. First Defense products are OMRI-listed for organic use, shelf-stable, and available in individual-dose and bulk formats for operations of all sizes.
Company Details
- Headquarters:
- Portland, Maine
- Founded:
- 1982
- Website:
- https://www.firstdefensecalfhealth.com/
Product Categories
First Defense Calf Health operates across multiple segments of the dairy industry, providing solutions in the following areas:
- Calf Scours Prevention
- Antibody Therapy
- Veterinary Biologics
- Passive Immunity Products